Infections in patients with lymphoproliferative diseases treated with brentuximab vedotin: SEIFEM multicentric retrospective study

Leuk Lymphoma. 2020 Dec;61(12):3002-3005. doi: 10.1080/10428194.2020.1786562. Epub 2020 Jul 1.
No abstract available

Publication types

  • Letter

MeSH terms

  • Brentuximab Vedotin
  • Hodgkin Disease* / complications
  • Hodgkin Disease* / drug therapy
  • Humans
  • Immunoconjugates* / adverse effects
  • Lymphoproliferative Disorders* / drug therapy
  • Retrospective Studies

Substances

  • Immunoconjugates
  • Brentuximab Vedotin